HDAC3 and acute myeloid leukemia: Moreover, we here confirm our data for FLT3-ITD positive AML cells that are treated with combinations of panobinostat plus AC220 (Pietschmann et al. 2012) and extend them by showing a survival dependency of FLT3i-treated leukemic cells on HDAC3.